ReviewFrontiers in pharmacology2026

Non-small cell lung cancer after EGFR-TKI resistance: from drug resistance mechanisms to precision interventions.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.